THERATRAQ Trademark

Trademark Overview

On Wednesday, August 28, 2019, a trademark application was filed for THERATRAQ with the United States Patent and Trademark Office. The USPTO has given the THERATRAQ trademark a serial number of 88979225. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by SAI-MedPartners, LLC. The THERATRAQ trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business intelligence services for the healthcare industry
theratraq

General Information

Serial Number88979225
Word MarkTHERATRAQ
Filing DateWednesday, August 28, 2019
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6202412
Registration DateTuesday, November 17, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Goods and ServicesBusiness intelligence services for the healthcare industry

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, September 10, 2019
Primary Code035
First Use Anywhere DateTuesday, September 15, 2020
First Use In Commerce DateTuesday, September 15, 2020

Trademark Owner History

Party NameSAI-MedPartners, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressReading, PA 19606
Party NameSAI-MedPartners, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressReading, PA 19606
Party NameSAI-MedPartners, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressReading, PA 19606

Trademark Events

Event DateEvent Description
Saturday, August 31, 2019NEW APPLICATION ENTERED
Tuesday, September 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 2, 2019ASSIGNED TO EXAMINER
Monday, December 9, 2019NON-FINAL ACTION WRITTEN
Monday, December 9, 2019NON-FINAL ACTION E-MAILED
Monday, December 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 12, 2020ASSIGNED TO LIE
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, September 15, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 15, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, October 7, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, September 15, 2020USE AMENDMENT FILED
Wednesday, October 7, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, October 12, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 13, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Monday, November 17, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

theratraq industry healthcare services intelligence business